Revatio
Active substance: sildenafil
POWDER, FOR SUSPENSION · SILDENAFIL CITRATE 10 mg/mL
United StatesActive
Marketing holder: Viatris Specialty LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- SILDENAFIL CITRATE · 10 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 85 |
|
| EU 10 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3012-76e0-bebf-939eef6c1caf,01a120c3-31de-75ed-84ff-2a1d8fb395f1,01a120c3-35c3-7361-83b2-0fe24282f3a0,01a120c3-36e3-776a-b237-a8f517ecaba7,01a120c3-3709-7d2c-b748-9e54f1441454;count=76 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29b0-72f2-9821-bcd9abf084e5,01a1208c-2b0a-7342-a420-b6444ba91f5f,01a1208c-2cd4-7a4b-8e07-7e12c4f0efa9,01a1208c-2d01-7eca-93fd-c0db0a624489,01a1208c-2d26-7f38-b57b-74b9b96d75eb;count=235 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 58151-385
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 58151-385 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58151-385 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58151-385 · Verified 2026-10-09 · open in source